Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in prenatal screening.

Andrew McLennan1

  • 1Royal North Shore Hospital, Maternal Fetal Medicine Unit, Sydney. andrew.mclennan@sufw.com.au

Australian Family Physician
|April 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeat cell-free DNA screening after initial false-positive results and term placental analysis for confined mosaicism: a prospective cohort study.

Archives of gynecology and obstetrics·2025
Same author

External validation of the Fetal Medicine Foundation model for preterm pre-eclampsia prediction at 11-14 weeks in an Australian population.

Acta obstetricia et gynecologica Scandinavica·2025
Same author

Patient Preferences and Understanding of Genome-Wide Cell-Free DNA Screening for Foetal Chromosomal Imbalances: A Survey Study.

Prenatal diagnosis·2025
Same author

Simplified First-Trimester Fetal Cardiac Screening Protocol for Low-Risk Pregnancies: Enhancing Efficiency and Accuracy.

Australasian journal of ultrasound in medicine·2025
Same author

Virtual reality-guided mindfulness for chronic pain in cancer survivors: protocol for the virtual mind study-a single-group feasibility trial.

Frontiers in pain research (Lausanne, Switzerland)·2024
Same author

Prospective validity of a clinical prediction rule for response to non-surgical multidisciplinary management of knee osteoarthritis in tertiary care: a multisite prospective longitudinal study.

BMJ open·2024
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

General practitioners (GPs) must be knowledgeable about prenatal screening for Down syndrome and cystic fibrosis. First-trimester screening offers high detection rates for Down syndrome, but widespread cystic fibrosis screening is debated.

Area of Science:

  • Obstetrics and Gynecology
  • Medical Genetics
  • Primary Care Medicine

Background:

  • Decreasing numbers of obstetric specialists lead to later first antenatal visits (after 14 weeks).
  • General Practitioners (GPs) are increasingly responsible for prenatal screening and diagnostic advice.
  • GPs require updated knowledge on common chromosomal and genetic abnormalities.

Purpose of the Study:

  • To inform GPs about current prenatal screening strategies.
  • To highlight the importance of screening for Down syndrome and cystic fibrosis.
  • To discuss the implications of widespread prenatal genetic screening.

Main Methods:

  • Review of current prenatal screening techniques.
  • Assessment of detection rates for Down syndrome screening.

Related Experiment Videos

  • Consideration of resources and ethical debates surrounding genetic screening.

    • Main Results:

    • Combined first-trimester nuchal translucency and biochemical screening is highly effective for Down syndrome (approx. 90% detection).
    • Antenatal screening for cystic fibrosis is beneficial for high-risk individuals.
    • Routine screening for all pregnant women faces resource and ethical challenges.

    Conclusions:

    • GPs play a crucial role in providing prenatal screening information.
    • First-trimester screening is the most reliable method for Down syndrome detection.
    • Widespread genetic screening requires careful consideration of resources and counseling.